Clinical trial NCT02485847: IRIS Registry: Intelligent Research in Sight Registry
Official title: IRIS Registry: Intelligent Research in Sight Registry
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Eye Diseases
Keywords: Eye Diseases
Lead sponsor: American Academy of Ophthalmology
Sponsor class: OTHER
First posted: 2015-06-30
Enrollment: 20000000
Sex: ALL
Minimum age (years): 6
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: To ensure the IRIS Registry infrastructure is properly developed with features and functionalities that meets the needs of ophthalmologists, the IRIS Registry is currently only open to Academy members practicing in the United States and its territories.

Brief summary: The IRIS™ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excellence.

Detailed description: The IRIS Registry is primarily a clinical self-improvement tool. It will allow ophthalmologists to compare their patient outcomes, professional performance and care processes against other ophthalmologists across the country. The IRIS Registry will be able to measure the continuum of care from initial patient contact, through intervention and follow up.

Improve Patient Care - Monitor patient interactions, track interventions, identify and address gaps in quality of care, and measure quality outcomes.

Manage Patient Populations - Proactively manage clinical conditions for entire patient populations by running reports on specific care criteria.

Benchmark Your Practice - Identify practice strengths and weaknesses using the IRIS Registry's ophthalmology-specific clinical data from other practices to compare to the performance and outcomes data of your practice.

Run quality reports on demand - Providing clinician- and practice-level results, plus national results and patient-level detail for all IRIS Registry measures.

Enhance Quality and Practice Efficiency - Use the IRIS Registry data to analyze practice processes and procedures and as a source for fact-based decision-making. Because the IRIS Registry will capture data over time at the individual and practice level, it will help practices efficiently manage patient care and optimize practice resources.

Join a Community of Quality - Become a member of a like-minded community of quality-driven professionals striving to continuously improve patient care. Interact with your peers to create opportunities for sharing quality improvement strategies and broaden your professional network.

Eligibility criteria: Inclusion Criteria:

* Patients who meet the denominator requirements for each measure.

Exclusion Criteria:

* None

Primary outcomes:
measure: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
timeFrame: Up to 5 years
measure: Age-Related Macular Degeneration (AMD): Dilated Macular Examination
timeFrame: Up to 5 years
measure: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
timeFrame: Up to 5 years
measure: Diabetic Retinopathy: Communication with the Physician Managing On-going Diabetes Care
timeFrame: Up to 5 years
measure: Preventive Care and Screening: Influenza Immunization
timeFrame: Up to 5 years
measure: Pneumonia Vaccination Status for Older Adults
timeFrame: Up to 5 years
measure: Diabetes Mellitus: Dilated Eye Exam in Diabetic Patient
timeFrame: Up to 5 years
measure: Documentation of Current Medications in the Medical Record
timeFrame: Up to 5 years
measure: Melanoma: Continuity of Care - Recall System
timeFrame: Up to 5 years
measure: Melanoma: Coordination of Care
timeFrame: Up to 5 years
measure: Age-Related Macular Degeneration (AMD): Counseling on Antioxidant Supplement
timeFrame: Up to 5 years
measure: Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% or Documentation of a Plan of Care
timeFrame: Up to 5 years
measure: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
timeFrame: Up to 5 years
measure: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
timeFrame: Up to 5 years
measure: Melanoma: Overutilization of Imaging Studies in Melanoma
timeFrame: Up to 5 years
measure: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
timeFrame: Up to 5 years
measure: Controlling High Blood Pressure
timeFrame: Up to 5 years
measure: Use of High-Risk Medications in the Elderly
timeFrame: Up to 5 years
measure: Biopsy Follow-Up
timeFrame: Up to 5 years
measure: Improvement in Patient's Visual Function within 90 Days Following Cataract Surgery
timeFrame: Up to 5 years
measure: Patient Satisfaction within 90 Days Following Cataract Surgery
timeFrame: Up to 5 years
measure: Falls: Screening for Future Fall Risk
timeFrame: Up to 5 years
measure: Closing the Referral Loop: Receipt of Specialist Report
timeFrame: Up to 5 years
measure: Adult Primary Rhegmatogenous Retinal Detachment Repair Success Rate
timeFrame: Up to 5 years
measure: Adult Primary Rhegmatogenous Retinal Detachment Surgery Success Rate
timeFrame: Up to 5 years
measure: Cataract Surgery with Intra-Operative Complications (Unplanned Rupture of Posterior Capsule requiring unplanned vitrectomy)
timeFrame: Up to 5 years
measure: Cataract Surgery: Difference Between Planned and Final Refraction
timeFrame: Up to 5 years
measure: Tobacco Use and Help with Quitting Among Adolescents
timeFrame: Up to 5 years
measure: Corneal Graft: 20/40 or Better Visual Acuity within 90 Days following Corneal Graft Surgery
timeFrame: Up to 5 years
measure: Open-Angle Glaucoma: Intraocular Pressure Reduction
timeFrame: Up to 5 years
measure: Open-Angle Glaucoma: Visual Field Progression
timeFrame: Up to 5 years
measure: Open-Angle Glaucoma: Intraocular Pressure Reduction Following Laser Trabeculoplasty
timeFrame: Up to 5 years
measure: Acquired Involutional Ptosis: Improvement of Marginal Reflex Distance within 90 Days Following Surgery for Acquired Involutional Ptosis
timeFrame: Up to 5 years
measure: Acquired Involutional Entropion: Normalization of Eyelid Position within 90 Days Following Surgery for Acquired Involutional Entropion
timeFrame: Up to 5 years
measure: Amblyopia: Improvement of Corrected Interocular Visual Acuity Difference to 2 or fewer Lines
timeFrame: Up to 5 years
measure: Surgical Esotropia: Patients with Postoperative Alignment of 15 prism diopters or less
timeFrame: Up to 5 years
measure: Diabetic Retinopathy: Dilated Eye Exam
timeFrame: Up to 5 years
measure: Exudative Age-Related Macular Degeneration: Loss of Visual Acuity
timeFrame: Up to 5 years
measure: Nonexudative Age-Related Macular Degeneration: Loss of Visual Acuity
timeFrame: Up to 5 years
measure: Diabetic Macular Edema: Loss of Visual Acuity
timeFrame: Up to 5 years
measure: Rhegmatogenous Retinal Detachment Surgery: Visual acuity improvement within 90 days of surgery
timeFrame: Up to 5 years
measure: Rhegmatogenous Retinal Detachment Surgery: Return to the operating room within 90 days of surgery
timeFrame: Up to 5 years
measure: Acute Anterior Uveitis: Post-treatment visual acuity
timeFrame: Up to 5 years
measure: Acute Anterior Uveitis: Post-treatment Grade 0 anterior chamber cells
timeFrame: Up to 5 years
measure: Chronic Anterior Uveitis: Post-treatment visual acuity
timeFrame: Up to 5 years
measure: Chronic Anterior Uveitis: Post-treatment Grade 0 anterior chamber cells
timeFrame: Up to 5 years
Secondary outcomes:
Other outcomes:
Locations:
city: San Francisco
country: United States
facility: American Academy of Opthalmology
state: California
Study officials:
affiliation: American Academy of Ophthalmology
name: Flora Lum, MD
role: STUDY_DIRECTOR
References: